Dr. Reddy’s Partners With Department Of BIRAC For Sputnik V Vaccine Clinical Trials
Hyderabad, Oct. 29 (Hydnow): Dr. Reddy’s Laboratories Ltd. announced its partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support on clinical…
Dr. Reddy’s Labs. Announces Appointment Of New Chief Financial Officer
Hyderabad, Oct.28 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced that Parag Agarwal will be joining the Company as Chief Financial Officer (Designate) on November 2, 2020. The Board of Directors…
Dr. Reddy’s Labs. Launches New Medicine In US Market
Hyderabad, Oct.3 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. “We are pleased to launch this generic version…
Dr. Reddy’s Laboratories Launched New Capsule Approved By USFDA
Hyderabad, sept.26 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfidera® (dimethyl fumarate) Delayed-Release Capsules, approved by the…
Dr. Reddy’s Announces Launch Of An Injection Approved By USFDA
Hyderabad, sept.25 (Hydnow): Dr. Reddy’s Laboratories Ltd. announced launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a therapeutic equivalent generic version of Precedex® (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride…
Dr. Reddy’s Launched Olopatadine Hydrochloride Ophthalmic Solution USP
Hyderabad, Sept.17 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalents of Pataday Once Daily Relief…
Dr. Reddy’s Laboratories Announces The Launch Of Redyx In India
Hyderabad, Sept.9 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of Remdesivir, under a brand name Redyx in India. The launch is part of the licensing agreement with Gilead…
Dr. Reddy’s Laboratories Announces Launch Of Fulvestrant Injection
Hyderabad, Sept.7 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant)…
Dr Reddy’s Launches Avigan (Favipiravir) In India For COVID-19
Hyderabad, Aug.19 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of Avigan (Favipiravir) 200 mg Tablets in India. The launch is part of the global licensing agreement with Fujifilm…
Dr. Reddy’s Partners With FUJIFILM And Global Response Aid For Avigan
Hyderabad, July 1 (Hydnow): Dr. Reddy’s Laboratories Ltd. said partnering with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. (hereafter referred to as “FUJIFILM”) and Global Response Aid (GRA) for…